TNFRSF4 and neoplasm: OX40 activation after OX40L treatment substantially increased cell proliferative ability (Supplemental Figure 2B), migratory ability (Supplemental Figure 2C), tube-forming capacity (Supplemental Figure 2D), and tumor cell transendothelial migratory ability (Supplemental Figure 2, E and F).